Newgenivf Group Limited Stock Performance
| NIVF Stock | 0.38 0.02 5.56% |
On a scale of 0 to 100, NewGenIvf Group holds a performance score of 2. The company secures a Beta (Market Risk) of -3.62, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning NewGenIvf Group are expected to decrease by larger amounts. On the other hand, during market turmoil, NewGenIvf Group is expected to outperform it. Please check NewGenIvf Group's downside variance, as well as the relationship between the accumulation distribution and price action indicator , to make a quick decision on whether NewGenIvf Group's current price movements will revert.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in NewGenIvf Group Limited are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, NewGenIvf Group reported solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | NewGenIvf Receives Nasdaq Notification Regarding Minimum Bid Price | 10/14/2024 |
2 | NewGenIvf Enters into a Binding Term Sheet with White Lion Capital for 100 Million Equity Line ... | 11/18/2024 |
3 | NewGenIvf Receives Nasdaq Delisting Notice and Plans to Submit Appeal, Announces Strategic Path ... | 11/22/2024 |
4 | NewGen Signs Binding Term Sheet for Reverse Merger with European Wellness Investment Holdings | 12/11/2024 |
| Begin Period Cash Flow | 54.7 K | |
| Free Cash Flow | -927.2 K |
NewGenIvf |
NewGenIvf Group Relative Risk vs. Return Landscape
If you would invest 70.00 in NewGenIvf Group Limited on September 14, 2024 and sell it today you would lose (32.00) from holding NewGenIvf Group Limited or give up 45.71% of portfolio value over 90 days. NewGenIvf Group Limited is currently generating 0.6978% in daily expected returns and assumes 23.3229% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than NewGenIvf, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NewGenIvf Group Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NewGenIvf Group's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as NewGenIvf Group Limited, and traders can use it to determine the average amount a NewGenIvf Group's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0299
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NIVF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 23.32 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.7 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average NewGenIvf Group is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NewGenIvf Group by adding it to a well-diversified portfolio.
NewGenIvf Group Fundamentals Growth
NewGenIvf Stock prices reflect investors' perceptions of the future prospects and financial health of NewGenIvf Group, and NewGenIvf Group fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NewGenIvf Stock performance.
| Current Valuation | 7.37 M | ||||
| Price To Book | 7.91 X | ||||
| Price To Sales | 1.38 X | ||||
| Revenue | 5.14 M | ||||
| EBITDA | (2.52 M) | ||||
| Net Income | (690.85 K) | ||||
| Total Debt | 1.62 M | ||||
| Cash Flow From Operations | (857.36 K) | ||||
| Market Capitalization | 7.09 M | ||||
| Total Asset | 21.32 M | ||||
| Retained Earnings | (5.67 M) | ||||
| Working Capital | 79 K | ||||
About NewGenIvf Group Performance
By analyzing NewGenIvf Group's fundamental ratios, stakeholders can gain valuable insights into NewGenIvf Group's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if NewGenIvf Group has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NewGenIvf Group has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 13.34 | 14.01 | |
| Return On Tangible Assets | (0.42) | (0.40) | |
| Return On Capital Employed | 0.08 | 0.08 | |
| Return On Assets | (0.42) | (0.40) | |
| Return On Equity | (0.04) | (0.04) |
Things to note about NewGenIvf Group performance evaluation
Checking the ongoing alerts about NewGenIvf Group for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NewGenIvf Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NewGenIvf Group is way too risky over 90 days horizon | |
| NewGenIvf Group has some characteristics of a very speculative penny stock | |
| NewGenIvf Group appears to be risky and price may revert if volatility continues | |
| NewGenIvf Group has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 5.14 M. Net Loss for the year was (690.85 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| NewGenIvf Group generates negative cash flow from operations | |
| NewGenIvf Group has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: NewGen Signs Binding Term Sheet for Reverse Merger with European Wellness Investment Holdings |
- Analyzing NewGenIvf Group's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NewGenIvf Group's stock is overvalued or undervalued compared to its peers.
- Examining NewGenIvf Group's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NewGenIvf Group's management team can have a significant impact on its success or failure. Reviewing the track record and experience of NewGenIvf Group's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NewGenIvf Group's stock. These opinions can provide insight into NewGenIvf Group's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for NewGenIvf Stock analysis
When running NewGenIvf Group's price analysis, check to measure NewGenIvf Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewGenIvf Group is operating at the current time. Most of NewGenIvf Group's value examination focuses on studying past and present price action to predict the probability of NewGenIvf Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewGenIvf Group's price. Additionally, you may evaluate how the addition of NewGenIvf Group to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |